Program Description:
Like hyperlipidemia and hypertension, diabetes means elevated risk for cardiovascular disease. Management—and patient adherence—can be particularly challenging when these conditions are comorbid. Here, a 64-year-old man whose hyperlipidemia and hypertension are controlled resists taking the additional steps necessary when he is diagnosed with type 2 diabetes mellitus, even though he appears to be experiencing complications related to his diabetes.
INTENDED AUDIENCE:
Primary care physicians, physician assistants, and nurse practitioners.
Activity Objectives:
After taking part in this educational activity, participants should be better able to:
- Identify patients who are at risk for cardiovascular (CV) complications due to comorbid diabetes and dyslipidemia
- Explain the pathophysiologic interrelationship among CV disease, diabetes, and dyslipidemia
- Implement patient-specific therapeutic strategies to achieve optimal glycemic and lipid levels
- Educate patients about CV risk reduction through adherence to a combined regimen of medication use and therapeutic lifestyle changes
|
Credits
|
Type
|
Accreditation Statement
|
Designation Statement
|
|
0.50
|
AMA PRA Category 1 Credit(s)TM
|
Albert Einstein College of Medicine of Yeshiva University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
|
Albert Einstein designates this enduring educational activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
|
Faculty:
Program Co-chairs
Michael Davidson, MD
Clinical Professor of Medicine
Director, Preventive Cardiology
University of Chicago Medical Center
Chicago, IL
Jorge Plutzky, MD
Director, The Vascular Disease Prevention Program
Brigham and Women's Hospital
Harvard Medical School
Brigham & Women's Hospital
Cardiovascular Medicine
Boston, MA
CME Course Director
Daniel Thomas Stein, MD
Professor, Department of Medicine (Endocrinology)
Albert Einstein College of Medicine of Yeshiva University
Bronx, NY
Disclosures:
Conflict of Interest
The Conflict of Interest Disclosure Policy of Albert Einstein College of Medicine of Yeshiva University requires that faculty participating in any CME activity disclose to the audience any relationship(s) with a pharmaceutical or equipment company. Any presenter whose disclosed relationships prove to create a conflict of interest with regard to their contribution to the activity will not be permitted to present.
Faculty Disclosures
Michael Davidson, MD, is on the board of directors of Omthera Pharmaceuticals, and is a consultant for Amgen Inc, AstraZeneca, Merck & Co., Inc., and sanofi-aventis.
Jorge Plutzky, MD, is a consultant for Abbott, Amylin Pharmaceuticals, Bristol-Myers Squibb, Daiichi Sankyo, GlaxoSmithKline, Merck & Co. Inc., Novo Nordisk, Orexigen, Pfizer, Roche/Genentech, Takeda, and Vivus.
Daniel Thomas Stein, MD, has nothing to disclose.
Staff Disclosures
Jill Rovitzky Black and Melissa Johnson, Haymarket Medical Education, have nothing to disclose with regard to commercial support.
The staff of Albert Einstein College of Medicine has nothing to disclose relative to this CME activity.
Disclosure of Unlabeled Use
This educational activity may contain discussion of approved and/or investigational uses of agents that are not indicated by the FDA. Albert Einstein College of Medicine, Daiichi Sankyo, Inc., and Haymarket Medical Education do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Albert Einstein College of Medicine, Daiichi Sankyo, Inc., and Haymarket Medical Education. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Privacy Policy
To view the myCME privacy policy, please click here.
To view the Albert Einstein College of Medicine of Yeshiva University privacy policy, please click here.
Accredited Provider:
Sponsored by Albert Einstein College of Medicine of Yeshiva University
Produced by Haymarket Medical Education
Commercial Supporter:
This program supported by an educational grant from Daiichi Sankyo, Inc.
Instructions:
To obtain credit, a score of 70% or better is required. This CME is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the posttest survey, and have received your digital copy of your credit certificate. Your online certificate will be saved on myCME.com within your Profile/Exam History, which you can then access at any time.
If you have any questions relating to the accreditation of this activity, please contact Mildred Adighiuzor, Associate Director, CME Business & Marketing, at 718-920-6674.
SYSTEM REQUIREMENTS:
WINDOWS PC SYSTEM REQUIREMENTS:
266-MHz Pentium II; Windows 98 or higher; 64 MB RAM; 800 x 600 screen resolution
set for “High Color (16-Bit)”; Macromedia Flash Player 6 or higher.
MACINTOSH® SYSTEM REQUIREMENTS:
Power Mac g3 at 300 MHz; System 8.5 or higher (excluding Mac OSX); 96 MB RAM; 20
MB minimum hard disk space available; 800 x 600 screen resolution set to “Thousands
of Colors”; Macromedia Flash Player 6 or higher.